Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

How Philadelphia startup Proscia is bringing cancer biopsies into the digital age

By Author Proscia | May 20, 2024

Proscia was profiled in Fast Company for our work transforming the practice of pathology. Reporter Adam Bluestein refers to Proscia as the “AWS of cancer,” highlighting our traction accelerating digital pathology and AI adoption. He also includes commentary from PathGroup’s Chief Medical Officer Dr. Derek Welch, who notes that his pathologists exclusively use Concentriq.

Our website uses cookies. By using this site, you agree to its use of cookies.